Reduction of CLABSI rates is a top priority for Level IV NICUs due to the significant short- and long-term impacts for patients. Benchmarking with other NICUs is a valuable practice when neonatal-specific research is unavailable.
Velasco et al. (Tue,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: